Search results
Added:
3 years ago
Among patients undergoing surgical valve replacement, 1–5 % of patients with an aortic valve replacement (AVR) and 2–12 % with a mitral valve replacement (MVR) may develop paravalvular regurgitation or ‘leak’ (PVL).1–3 In the era of transcatheter aortic valve replacement (TAVR) with first-generation balloon expandable valves, up to 17 % of patients may be left with moderate or severe PVL, also…
View more
Added:
3 years ago
Paravalvular leak (PVL) occurs when there is backflow around a prosthetic valve. This can occur through a variety of causes. Paravalvular Leak is accompanied by regurgitation and is often a significant problem for patients with bioprosthetic or mechanical heart valves.1 Often manifesting as heart failure (85% of all presenting symptoms) and hemolysis (13–47% of all presenting symptoms and signs)…
View more
Added:
2 years ago
Prof Lars Søndergaard (Copenhagen University Hospital, Copenhagen, DK) discusses the 30-day outcomes from the Portico NG Study. The clinical study assessed the acute safety and effectiveness of the next-generation Portico™ NG Transcatheter Aortic Heart Valve.
Questions
1. Can you tell us more about the studied device and how it differs from the Portico™ TAVR?
2. What was the design, patient…
View more
Added:
2 years ago
Added:
3 years ago
Imaging guidance is of major importance for successful outcomes in the interventional treatment of structural, congenital and valvular heart disease. Cardiac transcatheter treatment of these diseases is a rapidly growing field and, as a result, there has been substantial progress in image-guidance technology.
During interventions, the major imaging focus is currently on echocardiography, which…
View more
Added:
2 years ago
In this interview, Dr Andreas Rück (Karolinska University Hospital, Stockholm, SE) outlines the findings of the Early Neo2 Registry, which tracked the performance of the ACURATE Neo2 TAVI Valve device, which released in September 2020.
Questions:
What is the rationale for this registry?
Can you tell us more about the Acurate neo2 Device?
What data are you tracking and how many patients have you…
View more
David Northridge
Author
Added:
1 year ago
Dr Andrea Buono (Fondazione Poliambulanza Hospital, Brescia, IT) joins us at EuroPCR 2022 in a short interview outlining the findings of a short-term study on the post-procedural outcomes in patients treated with the ACURATE neo2™ device. Outcomes show a significant reduction of the primary endpoint with the use of the next-generation aortic valve system.
Discussion points:
1. Background of this…
View more
Eduardo A Arias
Research Area(s) / Expertise:
Author
